Metropolis Healthcare Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹1384.2
- Today's High:
- ₹1430.3
- Open Price:
- ₹1414.1
- 52W Low:
- ₹1176.05
- 52W High:
- ₹1789
- Prev. Close:
- ₹1418.25
- Volume:
- 7794
Company Statistics
- Market Cap.:
- ₹70.99 billion
- Book Value:
- 192.974
- Revenue TTM:
- ₹11.45 billion
- Operating Margin TTM:
- 17.33%
- Gross Profit TTM:
- ₹9.10 billion
- Profit Margin:
- 12.07%
- Return on Assets TTM:
- 8.21%
- Return on Equity TTM:
- 15.26%
Company Profile
Metropolis Healthcare Limited had its IPO on under the ticker symbol METROPOLIS.
The company operates in the Healthcare sector and Diagnostics & Research industry. Metropolis Healthcare Limited has a staff strength of 4,300 employees.
Stock update
Shares of Metropolis Healthcare Limited opened at ₹1414.1 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹1384.2 - ₹1430.3, and closed at ₹1397.6.
This is a -1.46% slip from the previous day's closing price.
A total volume of 7,794 shares were traded at the close of the day’s session.
In the last one week, shares of Metropolis Healthcare Limited have increased by +1.42%.
Metropolis Healthcare Limited's Key Ratios
Metropolis Healthcare Limited has a market cap of ₹70.99 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Metropolis Healthcare Limited’s revenue was ₹11.45 billion with a gross profit of ₹9.10 billion and an EBITDA of ₹2.32 billion. The EBITDA ratio measures Metropolis Healthcare Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Metropolis Healthcare Limited’s operating margin was 17.33% while its return on assets stood at 8.21% with a return of equity of 15.26%.
In Q2, Metropolis Healthcare Limited’s quarterly earnings growth was a negative -13.6% while revenue growth was a negative 1%.
Metropolis Healthcare Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 51.4477
- PEG
Its diluted EPS in the last 12-months stands at ₹26.94 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Metropolis Healthcare Limited’s profitability.
Metropolis Healthcare Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Metropolis Healthcare Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 29.72%.
Balance sheet and cash flow metrics
- Total Assets
- ₹15.02 billion
- Total Liabilities
- ₹2.65 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 29.72%
Metropolis Healthcare Limited ended 2024 with ₹15.02 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹15.02 billion while shareholder equity stood at ₹9.88 billion.
Metropolis Healthcare Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹2.65 billion in other current liabilities, in common stock, ₹7.82 billion in retained earnings and ₹4.55 billion in goodwill. Its cash balance stood at ₹688.33 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹286.14 million.
Metropolis Healthcare Limited’s total current assets stands at ₹3.03 billion while long-term investments were ₹0 and short-term investments were ₹514.79 million. Its net receivables were ₹1.22 billion compared to accounts payable of ₹940.82 million and inventory worth ₹445.91 million.
In 2024, Metropolis Healthcare Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Metropolis Healthcare Limited paid ₹0.30 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹1397.6
- 52-Week High
- ₹1789
- 52-Week Low
- ₹1176.05
- Analyst Target Price
- ₹
Metropolis Healthcare Limited stock is currently trading at ₹1397.6 per share. It touched a 52-week high of ₹1789 and a 52-week low of ₹1789. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹1395.1 and 200-day moving average was ₹1337.34 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 4974.2% of the company’s stock are held by insiders while 3162.1% are held by institutions.
Frequently Asked Questions About Metropolis Healthcare Limited
Similar Industry Stocks (Diagnostics & Research)
Most Active
Top Gainers
Top Losers
About
Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, and diagnosis of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.